Log in with your email address username.


[Editorial] UK life science research: time to burst the biomedical bubble

In November, 2017, as part of her long-awaited industrial strategy, UK Prime Minister Theresa May committed to raise investment in research and development (R&D) to 2·4% of gross domestic product by 2027. Life sciences featured prominently in the industrial strategy, described as one of the dominant economic sectors in the UK. A new strategic funding agency—UK Research and Innovation (UKRI)—was created to oversee the allocation of these funds, bringing seven research councils together in a major shake-up of the UK’s funding structure.